Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × selinexor × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 17 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 5 Sarcoma 3 Neurofibrosarcoma 3 Primary Myelofibrosis 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Glioblastoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vascular Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡